BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 22511559)

  • 1. Clinically oriented three-step strategy for assessment of adnexal pathology.
    Ameye L; Timmerman D; Valentin L; Paladini D; Zhang J; Van Holsbeke C; Lissoni AA; Savelli L; Veldman J; Testa AC; Amant F; Van Huffel S; Bourne T
    Ultrasound Obstet Gynecol; 2012 Nov; 40(5):582-91. PubMed ID: 22511559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lesion size affects diagnostic performance of IOTA logistic regression models, IOTA simple rules and risk of malignancy index in discriminating between benign and malignant adnexal masses.
    Di Legge A; Testa AC; Ameye L; Van Calster B; Lissoni AA; Leone FP; Savelli L; Franchi D; Czekierdowski A; Trio D; Van Holsbeke C; Ferrazzi E; Scambia G; Timmerman D; Valentin L
    Ultrasound Obstet Gynecol; 2012 Sep; 40(3):345-54. PubMed ID: 22611001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group.
    Timmerman D; Ameye L; Fischerova D; Epstein E; Melis GB; Guerriero S; Van Holsbeke C; Savelli L; Fruscio R; Lissoni AA; Testa AC; Veldman J; Vergote I; Van Huffel S; Bourne T; Valentin L
    BMJ; 2010 Dec; 341():c6839. PubMed ID: 21156740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods.
    Meys EMJ; Jeelof LS; Achten NMJ; Slangen BFM; Lambrechts S; Kruitwagen RFPM; Van Gorp T
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):784-792. PubMed ID: 27514486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External validation of IOTA simple descriptors and simple rules for classifying adnexal masses.
    Alcázar JL; Pascual MA; Graupera B; Aubá M; Errasti T; Olartecoechea B; Ruiz-Zambrana A; Hereter L; Ajossa S; Guerriero S
    Ultrasound Obstet Gynecol; 2016 Sep; 48(3):397-402. PubMed ID: 26748432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help.
    Valentin L; Ameye L; Savelli L; Fruscio R; Leone FP; Czekierdowski A; Lissoni AA; Fischerova D; Guerriero S; Van Holsbeke C; Van Huffel S; Timmerman D
    Ultrasound Obstet Gynecol; 2011 Oct; 38(4):456-65. PubMed ID: 21520475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective external validation of IOTA three-step strategy for characterizing and classifying adnexal masses and retrospective assessment of alternative two-step strategy using simple-rules risk.
    Hidalgo JJ; Ros F; Aubá M; Errasti T; Olartecoechea B; Ruiz-Zambrana Á; Alcázar JL
    Ultrasound Obstet Gynecol; 2019 May; 53(5):693-700. PubMed ID: 30353585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra- and interobserver agreement when describing adnexal masses using the International Ovarian Tumor Analysis terms and definitions: a study on three-dimensional ultrasound volumes.
    Sladkevicius P; Valentin L
    Ultrasound Obstet Gynecol; 2013 Mar; 41(3):318-27. PubMed ID: 22915506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subjective assessment versus ultrasound models to diagnose ovarian cancer: A systematic review and meta-analysis.
    Meys EM; Kaijser J; Kruitwagen RF; Slangen BF; Van Calster B; Aertgeerts B; Verbakel JY; Timmerman D; Van Gorp T
    Eur J Cancer; 2016 May; 58():17-29. PubMed ID: 26922169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian cancer prediction in adnexal masses using ultrasound-based logistic regression models: a temporal and external validation study by the IOTA group.
    Timmerman D; Van Calster B; Testa AC; Guerriero S; Fischerova D; Lissoni AA; Van Holsbeke C; Fruscio R; Czekierdowski A; Jurkovic D; Savelli L; Vergote I; Bourne T; Van Huffel S; Valentin L
    Ultrasound Obstet Gynecol; 2010 Aug; 36(2):226-34. PubMed ID: 20455203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving strategies for diagnosing ovarian cancer: a summary of the International Ovarian Tumor Analysis (IOTA) studies.
    Kaijser J; Bourne T; Valentin L; Sayasneh A; Van Holsbeke C; Vergote I; Testa AC; Franchi D; Van Calster B; Timmerman D
    Ultrasound Obstet Gynecol; 2013 Jan; 41(1):9-20. PubMed ID: 23065859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ADNEX model to triage adnexal masses: An external validation study and comparison with the IOTA two-step strategy and subjective assessment by an experienced ultrasound operator.
    Viora E; Piovano E; Baima Poma C; Cotrino I; Castiglione A; Cavallero C; Sciarrone A; Bastonero S; Iskra L; Zola P
    Eur J Obstet Gynecol Reprod Biol; 2020 Apr; 247():207-211. PubMed ID: 32146226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prospective External Validation of International Ovarian Tumor Analysis (IOTA) Simple Rules in the Hands of Level I and II Examiners.
    Knafel A; Banas T; Nocun A; Wiechec M; Jach R; Ludwin A; Kabzinska-Turek M; Pietrus M; Pitynski K
    Ultraschall Med; 2016 Oct; 37(5):516-523. PubMed ID: 26126150
    [No Abstract]   [Full Text] [Related]  

  • 14. A multicenter prospective external validation of the diagnostic performance of IOTA simple descriptors and rules to characterize ovarian masses.
    Sayasneh A; Kaijser J; Preisler J; Johnson S; Stalder C; Husicka R; Guha S; Naji O; Abdallah Y; Raslan F; Drought A; Smith AA; Fotopoulou C; Ghaem-Maghami S; Van Calster B; Timmerman D; Bourne T
    Gynecol Oncol; 2013 Jul; 130(1):140-6. PubMed ID: 23578539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective evaluation of IOTA logistic regression models LR1 and LR2 in comparison with subjective pattern recognition for diagnosis of ovarian cancer in an outpatient setting.
    Nunes N; Ambler G; Foo X; Widschwendter M; Jurkovic D
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):829-835. PubMed ID: 28976616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group.
    Timmerman D; Van Calster B; Testa A; Savelli L; Fischerova D; Froyman W; Wynants L; Van Holsbeke C; Epstein E; Franchi D; Kaijser J; Czekierdowski A; Guerriero S; Fruscio R; Leone FPG; Rossi A; Landolfo C; Vergote I; Bourne T; Valentin L
    Am J Obstet Gynecol; 2016 Apr; 214(4):424-437. PubMed ID: 26800772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound-based logistic regression model LR2 versus magnetic resonance imaging for discriminating between benign and malignant adnexal masses: a prospective study.
    Shimada K; Matsumoto K; Mimura T; Ishikawa T; Munechika J; Ohgiya Y; Kushima M; Hirose Y; Asami Y; Iitsuka C; Miyamoto S; Onuki M; Tsunoda H; Matsuoka R; Ichizuka K; Sekizawa A
    Int J Clin Oncol; 2018 Jun; 23(3):514-521. PubMed ID: 29236181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the preoperative classification of adnexal masses as benign or malignant by second-stage tests.
    Daemen A; Valentin L; Fruscio R; Van Holsbeke C; Melis GB; Guerriero S; Czekierdowski A; Jurkovic D; Ombelet W; Rossi A; Vergote I; Bourne T; De Moor B; Timmerman D
    Ultrasound Obstet Gynecol; 2011 Jan; 37(1):100-6. PubMed ID: 20814878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IOTA simple rules for discriminating between benign and malignant adnexal masses: prospective external validation.
    Alcázar JL; Pascual MÁ; Olartecoechea B; Graupera B; Aubá M; Ajossa S; Hereter L; Julve R; Gastón B; Peddes C; Sedda F; Piras A; Saba L; Guerriero S
    Ultrasound Obstet Gynecol; 2013 Oct; 42(4):467-71. PubMed ID: 23576304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicentre external validation of IOTA prediction models and RMI by operators with varied training.
    Sayasneh A; Wynants L; Preisler J; Kaijser J; Johnson S; Stalder C; Husicka R; Abdallah Y; Raslan F; Drought A; Smith AA; Ghaem-Maghami S; Epstein E; Van Calster B; Timmerman D; Bourne T
    Br J Cancer; 2013 Jun; 108(12):2448-54. PubMed ID: 23674083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.